225
Views
0
CrossRef citations to date
0
Altmetric
Research

Development of a Malaysian potentially inappropriate prescribing screening tool in older adults (MALPIP): a Delphi study

ORCID Icon, , , , , , , , , , , , , , , , , , , , , , & show all
Article: 122 | Received 04 Jul 2023, Accepted 03 Oct 2023, Published online: 11 Mar 2024

References

  • Ageing and health. World Health Organization Fact Sheet. 2022. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. Accessed 16 May 2023.
  • Fan Z-Y, Yang Y, Zhang C-H, Yin R-Y, Tang L, Zhang FPrevalence and patterns of comorbidity among middle-aged and elderly people in China: a cross-sectional study based on CHARLS dataInt J Gen Med20211414491455 10.2147/IJGM.S309783 33907449 8071077
  • Liew NY, Chong YY, Yeow SH, Kua KP, Saw PS, Lee SWHPrevalence of potentially inappropriate medications among geriatric residents in nursing care homes in Malaysia: a cross-sectional studyInt J Clin Pharm201941895902 10.1007/s11096-019-00843-1 31073975
  • Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al.Prevalence and factors associated with polypharmacy: a systematic review and meta-analysisBMC Geriatr202222601 10.1186/s12877-022-03279-x 35854209 9297624
  • Rodrigues DA, Plácido AI, Mateos-Campos R, Figueiras A, Herdeiro MT, Roque FEffectiveness of interventions to reduce potentially inappropriate medication in older patients: a systematic reviewFront Pharmacol202112 10.3389/fphar.2021.777655 35140603
  • Kua C-H, Yeo CYY, Tan PC, Char CWT, Tan CWY, Mak V, et al.Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trialJ Am Med Dir Assoc2021228289 10.1016/j.jamda.2020.03.012 32423694
  • Reeve E, Gnjidic D, Long J, Hilmer SA systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practiceBr J Clin Pharmacol20158012541268 10.1111/bcp.12732 27006985 4693477
  • Curtin D, Gallagher PF, O’Mahony DExplicit criteria as clinical tools to minimize inappropriate medication use and its consequencesTher Adv Drug Saf2019102042098619829431 10.1177/2042098619829431 30800270 6378636
  • By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics SocietyUpdated AGS Beers Criteria® for potentially inappropriate medication use in older adultsJ Am Geriatr Soc2019201967674694
  • O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher PSTOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age Ageing201544213218 10.1093/ageing/afu145 25324330
  • Kua C-H, Mak VSL, Huey Lee SWHealth outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysisJ Am Med Dir Assoc201920362372.e11 10.1016/j.jamda.2018.10.026 30581126
  • Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris ISEffectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studiesJ Clin Pharm Ther201641158169 1:STN:280:DC%2BC28fhtlagsg%3D%3D 10.1111/jcpt.12372 26990017
  • Wehling M, Burkhardt H, Kuhn-Thiel A, Pazan F, Throm C, Weiss C, et al.VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classificationAge Ageing201645262267 10.1093/ageing/afv200 26786346
  • Chang C-B, Lai H-Y, Hwang S-J, Yang S-Y, Wu R-S, Chang L-Y, et al.The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older peopleTher Adv Chronic Dis2019102040622319879602 10.1177/2040622319879602 31632624 6779000
  • Fauziyah S, Andrajati R, Sartika RAD, Radji MAdaptation and validation of the screening tool of older people’s prescriptions instrument for the Indonesian populationJ Res Pharm Pract202092429 10.4103/jrpp.JRPP_19_106 32489957 7235452
  • Jun K, Lee S, Lee AY, Ah Y-M, Lee J-YDevelopment of a medication review tool for residents in Korean long-term care facilitiesTher Adv Chronic Dis20221320406223221128444 10.1177/20406223221128444 36225669 9549204
  • Kim M-Y, Etherton-Beer C, Kim C-B, Yoon JL, Ga H, Kim HC, et al.Development of a consensus list of potentially inappropriate medications for Korean older adultsAnn Geriatr Med Res201822121129 10.4235/agmr.2018.22.3.121 32743261 7387587
  • Chang CT, Teoh SL, Rajan P, Lee SWHExplicit potentially inappropriate medications criteria for older population in Asian countries: a systematic reviewRes Soc Adm Pharm RSAP2023S1551–74112300281284 10.1016/j.sapharm.2023.05.017
  • Holt S, Schmiedl S, Thürmann PAPotentially inappropriate medications in the elderly: the PRISCUS listDtsch Arzteblatt Int2010107543551
  • Laroche M-L, Charmes J-P, Merle LPotentially inappropriate medications in the elderly: a French consensus panel listEur J Clin Pharmacol200763725731 10.1007/s00228-007-0324-2 17554532
  • Nasa P, Jain R, Juneja DDelphi methodology in healthcare research: how to decide its appropriatenessWorld J Methodol202111116129 10.5662/wjm.v11.i4.116 34322364 8299905
  • Liu W, Hu M, Chen WIdentifying the service capability of long-term care facilities in China: an e-Delphi studyFront Public Health202210 10.3389/fpubh.2022.884514 35844860 9277176
  • Chang C-T, Mohd Shariff SM, Abu Bakar NS, Ramzuzzaman NS, Lim CK, Lim EYJ, et al.Polypharmacy and potentially inappropriate medications among hospitalized older adults with COVID-19 in Malaysian tertiary hospitalsJ Pharm Policy Pract2023162 10.1186/s40545-022-00504-1 36635766 9836327
  • Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJTThe safety and side effects of monoclonal antibodiesNat Rev Drug Discov20109325338 1:CAS:528:DC%2BC3cXjs1ehurw%3D 10.1038/nrd3003 20305665
  • Schiavo G, Forgerini M, Lucchetta RC, Mastroianni PCA comprehensive look at explicit screening tools for potentially inappropriate medication: a systematic scoping reviewAustralas J Ageing202241357382 10.1111/ajag.13046 35226786
  • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tablesJ Clin Epidemiol201164383394 10.1016/j.jclinepi.2010.04.026 21195583
  • The safety of medicines in public health programmes : pharmacovigilance, an essential tool. World Health Organization; 2006.
  • Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al.Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)JAMA Cardiol2020510361041 10.1001/jamacardio.2020.1834 32936252
  • Markowitz JD, Narasimhan MDelirium and antipsychotics: a systematic review of epidemiology and somatic treatment optionsPsychiatry Edgmont Pa Townsh200852936
  • Ahmed ADigoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrationsJ Gerontol A Biol Sci Med Sci200762323329 10.1093/gerona/62.3.323 17389731
  • Hilmer SN, Gnjidic DPrescribing for frail older peopleAust Prescr201740174178 10.18773/austprescr.2017.055 29109600 5662436
  • Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla NThe relationship between frailty and polypharmacy in older people: a systematic reviewBr J Clin Pharmacol20188414321444 10.1111/bcp.13590 29575094 6005607